BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30652093)

  • 1. Gut microbiome: a key player in cancer immunotherapy.
    Shigematsu Y; Inamura K
    Hepatobiliary Surg Nutr; 2018 Dec; 7(6):479-480. PubMed ID: 30652093
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer.
    Temraz S; Nassar F; Nasr R; Charafeddine M; Mukherji D; Shamseddine A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome and the Response to Immunotherapy in Cancer.
    Stancu AL
    Discoveries (Craiova); 2018 Sep; 6(3):e84. PubMed ID: 32309602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiome: an emerging key player in aging and longevity.
    Kim M; Benayoun BA
    Transl Med Aging; 2020; 4():103-116. PubMed ID: 32832742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of the Fecal Microbiome on Cancer Immunotherapy.
    Osman AEG; Luke JJ
    BioDrugs; 2019 Feb; 33(1):1-7. PubMed ID: 30604388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could the menagerie of the gut microbiome really cure cancer? Hope or hype.
    Abid MB
    J Immunother Cancer; 2019 Apr; 7(1):92. PubMed ID: 30940203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gut Microbiome: A New Player in Breast Cancer Metastasis.
    Ingman WV
    Cancer Res; 2019 Jul; 79(14):3539-3541. PubMed ID: 31308136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome and CAR-T therapy.
    Abid MB; Shah NN; Maatman TC; Hari PN
    Exp Hematol Oncol; 2019; 8():31. PubMed ID: 31827982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
    Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
    Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome modulates efficacy of immune checkpoint inhibitors.
    Yi M; Yu S; Qin S; Liu Q; Xu H; Zhao W; Chu Q; Wu K
    J Hematol Oncol; 2018 Mar; 11(1):47. PubMed ID: 29580257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma.
    Zheng Y; Wang T; Tu X; Huang Y; Zhang H; Tan D; Jiang W; Cai S; Zhao P; Song R; Li P; Qin N; Fang W
    J Immunother Cancer; 2019 Jul; 7(1):193. PubMed ID: 31337439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
    Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
    Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intimate relationship between gut microbiota and cancer immunotherapy.
    Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
    Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiome in Immuno-oncology.
    Toker J; Arora R; Wargo JA
    Adv Exp Med Biol; 2020; 1244():325-334. PubMed ID: 32301026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the Microbiome for Pancreatic Cancer Immunotherapy.
    Vitiello GA; Cohen DJ; Miller G
    Trends Cancer; 2019 Nov; 5(11):670-676. PubMed ID: 31735286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
    Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
    Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
    Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiota and immune checkpoint inhibitors.
    Humphries A; Daud A
    Hum Vaccin Immunother; 2018; 14(9):2178-2182. PubMed ID: 29494275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.